newsfilter
← Latest News
GlobeNewswire·

Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline results expected in